In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 178 for your search:
Cancer Type/Condition:  Brain tumor, child: Other
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: At least 3 to 5 years to under 22 years
Sponsor: Other
Protocol IDs: SIOP PNET 5 MB, 2011-004868-30, NCT02066220

2.

Phase: Phase III, Phase II
Type: Treatment
Status: Approved-not yet active
Age: 22 and under
Sponsor: Other
Protocol IDs: SIOP Ependymoma II (ET-13-002), 2013-002766-39, VHP358, NCT02265770

3.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 3 to 21
Sponsor: NCI, Other
Protocol IDs: ACNS0332, NCI-2009-00336, COG-ACNS0332, CDR0000511991, R01CA114567, U10CA098543, U10CA180886, NCT00392327

4.

Phase: Phase III
Type: Supportive care
Status: Active
Age: 1 to 21
Sponsor: Other
Protocol IDs: 06-08-367, NCT00726934

5.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 1 to 21
Sponsor: NCI, Other
Protocol IDs: ACNS0831, NCI-2011-02029, COG-ACNS0831, CDR0000668560, U10CA098543, NCT01096368

6.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 50 and under
Sponsor: NCI, Other
Protocol IDs: AEWS1031, NCI-2011-02611, COG-AEWS1031, CDR0000687639, U10CA098543, NCT01231906

7.

Phase: Phase III
Type: Supportive care
Status: Active
Age: 4 to 18
Sponsor: NCI, Other
Protocol IDs: SCUSF 1202, Previously COG-ACCL1032, 5U10CA081920, COG-ACCL1032, ACCL1032, NCT01346267

8.

Phase: Phase III
Type: Treatment
Status: Active
Age: 2 to 18
Sponsor: Other
Protocol IDs: CCHE-BT002, NCT01878266

9.

Phase: Phase III
Type: Treatment
Status: Approved-not yet active
Age: 1 to 25
Sponsor: NCI, Other
Protocol IDs: 2013-062, NCI-2013-02001, P30CA022453, NCT01987596

10.

Phase: Phase III
Type: Supportive care
Status: Active
Age: 5 to 17
Sponsor: Other
Protocol IDs: 1000039383, NCT02040376

11.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 2 to 32
Sponsor: Other
Protocol IDs: CNS 0201, NCT00179907

12.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 1 to 21
Sponsor: NCI, Other
Protocol IDs: ADVL0912, COG-ADVL0912, CDR0000647587, NCT00939770

13.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 1 to 30
Sponsor: Other
Protocol IDs: OHSU-5056, SOL-08131-L, NCT00983398

14.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 12 to 21
Sponsor: NCI
Protocol IDs: NCI-2012-03173, CDR667932, PBTC-029B, PBTC-029, UM1CA081457, U01CA081457, NCT01089101

15.

Phase: Phase II, Phase I
Type: Treatment
Status: Approved-not yet active
Age: 3 to 75
Sponsor: Other
Protocol IDs: NDV-HUJ-HMO-CTIL, NCT01174537

16.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 2 to 18
Sponsor: Pharmaceutical / Industry
Protocol IDs: DFI12860, 2010-019340-40, MOZ15609, NCT01288573

17.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 4 to 21
Sponsor: Other
Protocol IDs: 10-096, NCT01294670

18.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 21 and under
Sponsor: Other
Protocol IDs: Re-MATCH, W81XWH-10-1-0089, CDMRP-PRO93877, NCT01326104

19.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 21 and under
Sponsor: NCI
Protocol IDs: NCI-2012-00082, 12-C-0213, CDR0000717423, P12978, PBTC-033, U01CA081457, NCT01514201

20.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 17 and under
Sponsor: Other
Protocol IDs: 2011-0804, NCI-2011-03725, NCT01469247

21.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 12 and over
Sponsor: Other
Protocol IDs: 2010-0700, NCI-2012-00788, NCT01590069

22.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 3 and over
Sponsor: Other
Protocol IDs: 2011-0844, NCI-2012-00849, NCT01596127

23.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 2 to 18
Sponsor: Pharmaceutical / Industry
Protocol IDs: TED12689, U1111-1128-5704, NCT01751308

24.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 1 to 22
Sponsor: Other
Protocol IDs: 027812-HMO-CTIL, NCT01777633

25.

Phase: Phase II, Phase I
Type: Treatment
Status: Approved-not yet active
Age: 21 and under
Sponsor: Other
Protocol IDs: CCMC1311, NCT01837862
1     
New Search